Artificial-intelligence tools are no longer a side experiment for many Indian businesses. They are appearing in contract review, customer support, finance workflows, marketing review, and compliance triage. A board does not need to become a software committee, but it should know when an AI tool changes the risk profile of the business. The right question is not whether the tool sounds impressive. The right question is whether management can explain the use case, the data flow, the human review layer, and the exit plan.
A defensible approval process starts with classification. Low-risk drafting support may need departmental controls, while tools processing confidential client, employee, financial, or regulated information should be escalated. The board pack should identify the vendor, purpose, users, data categories, retention settings, access controls, and contractual protections. Where a listed entity is involved, the discipline should also align with broader risk-management and disclosure expectations under the SEBI LODR framework.
The official Supreme Court judgment titled Vishal Tiwari v Union of India and Others, while dealing with securities-market oversight, stressed constructive use of expert inputs and regulatory strengthening. The principle is useful by analogy: boards should not treat technology governance as a ceremonial approval. A committee note should record what was tested, what was rejected, and what conditions attach to deployment. If the minutes simply say "AI tool approved", the record is doing the legal equivalent of wearing sunglasses indoors.
Three controls usually matter. First, management should maintain an AI-use inventory with owner, purpose, and data sensitivity. Second, the contract should address confidentiality, data use for model training, audit support, breach notification, service levels, and termination assistance. Third, users should be trained to treat AI output as decision support, not as an automatic instruction. A human review trail is particularly important where the output affects legal, financial, HR, or regulatory decisions.
Boards should also ask for exception reporting. If users paste restricted data into an unapproved tool, if a vendor changes its terms, or if a tool produces unreliable outputs in a controlled test, the matter should not disappear into a helpdesk ticket. It should reach the appropriate governance forum with a remediation date. The discipline is simple: approve the use case, not the excitement around it.
For implementation, management should keep a compact evidence bundle for this topic: the approved policy or contract clause, the responsible owner, the last review date, the decision note, and any unresolved exception.
The bundle should be short enough for a busy director to read and complete enough for a later reviewer to understand the decision.
Where the matter is recurring, add a dashboard line showing open items, ageing, monetary exposure where relevant, and the next escalation date.
This keeps the board record factual without turning every issue into a bulky legal file.
It also helps counsel or advisers step in quickly if the matter becomes contentious.
A single owner should confirm closure in writing, because unsigned comfort is rarely comfortable later.
Keep it dated and useful.
If the board or committee chooses not to escalate a known exception, the reason should be recorded in plain terms.
A restrained record of judgment is usually stronger than a silent record of optimism.
The same pack should show what changed since the previous review, so directors are not forced to rediscover the history each quarter.
Where external advisers are involved, the note should also distinguish business instructions from legal advice, and operational updates from privileged review.
That distinction protects candour while keeping routine governance visible.
Short records can still be rigorous.
They should also show the next review owner, because unattended controls tend to become folklore.
AGS Consulting assists boards and management teams in preparing AI approval notes, vendor-risk summaries, and reviewable escalation records. For a focused review of governance controls around a proposed tool, write to AGS Consulting through the contact section.
FAQs
Does every AI tool need board approval?
No. Routine low-risk tools may remain at management level, but tools handling sensitive data or affecting regulated decisions should be escalated under the company policy.
What should an AI approval note include?
It should cover the use case, vendor, data categories, controls, human review, contractual protections, exit plan, and reporting cadence.
Can a board rely only on vendor assurances?
Vendor assurances help, but they should be tested against contract terms, security review, internal policy, and the company’s actual use case.
How often should approved AI use be reviewed?
A practical approach is quarterly reporting for higher-risk deployments and immediate escalation for data, security, or material performance exceptions.